Med. Pro Praxi 2009; 6(1): 30-33

Diagnosis and treatment of spondylarthritides

MUDr. Šárka Forejtová
Revmatologický ústav, Praha

Spondylarthritides represent a group of inflammatory rheumatic diseases commonly affecting the axial skeleton. Recently, their incidence

has been shown to be higher than previously thought. It has also been confirmed that the diagnosis of spondylarthritides is frequently

delayed. Therefore, a number of new diagnostic procedures have been developed which would allow the diagnosis of spondylarthritides

to be established earlier. A new definition of inflammatory spinal pain has been proposed or magnetic resonance imaging has been

included in the diagnostic algorithms. The paper deals with the current classification of spondylarthritides while providing a detailed

description of the clinical presentation as well as treatment of ankylosing spondylitis and reactive arthritis.

Keywords: spondylarthritides, inflammatory spinal pain, ankylosing spondylitis, reactive arthritis.

Published: March 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Forejtová Š. Diagnosis and treatment of spondylarthritides. Med. praxi. 2009;6(1):30-33.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Braun J, Bolow M, Remlinger G, et al. Prevalence of spondylartropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 1998; 41: 58-67. Go to original source...
    2. Hanova P, Pavelka K, Dostal C, Holcatova I, Pikhart H. Epidemiology of rheumatoid arthritis, juvenile idiopathic arthritis and gout in two regions of the Czech Republic in a descriptive population-based survey in 2002-2003. Clin Exp Rheumatol. 2006; 24(5): 499-507. Go to PubMed...
    3. Heenemann S, Daemen J. Cardiovascular risks in spondylathritides. Curr op rheumatol 2007; 19(4): 358-362. Go to original source... Go to PubMed...
    4. Sieper J, Appel H, Braun J, Rudwaeit M. Critical appraisal of assessment of structural damage in ankylosing spondylitis. Arthritis Rheum 2008; 58: 649-656. Go to original source... Go to PubMed...
    5. Pradeep DJ, Keat A, Gaffney K. Predicting outcome in ankylosing spondylitis. Rheumatology 2008; 47: 942-945. Go to original source... Go to PubMed...
    6. Rudwaleit M, Khan MA, Sieper J. The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria? Arthritis Rheum. 2005; 52(4): 1000-1008. Go to original source... Go to PubMed...
    7. Treitl M, Korner M, Becker-Gaab CH, et al. Magnetic Resonance imaging assessment of spinal inflammation in patients treated for ankylosing spondylitis. J Rheumatol 2008; 35: 126-136. Go to PubMed...
    8. Rudwaleit M, van der Heijde D, Khan MA, Braun J, Sieper J. How to diagnose axial spondyloarthritis early. Ann Rheum Dis. 2004; 63(5): 535-543. Go to original source... Go to PubMed...
    9. Lubrano E, D´Angelo S, Pardone WJ, et al. Effectiveness of rehabilitation in active ankylosing spondylitis assessed by the ASA response kriteria. Rheumatology 2007; 46: 1672-1675. Go to original source... Go to PubMed...
    10. Song IH, Poddubnyy A, Rudwalet M, Sieper J. Benefits and Risk sof ankylosing spondylitis tratment with nonsteroidal antiinflammatory drugs. Arthritis Rheum 2008; 56: 929-938. Go to original source... Go to PubMed...
    11. Wanders A, Heijde D, Landewe R, Behier JM, Calin A, Olivieri I, Zeidler H, Dougados M. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum. 2005; 52(6): 1756-1765. Go to original source... Go to PubMed...
    12. Zochling J. Assessment and treatment of ankylosing spondylitis: current status and future directions. Curr Opin Rheumatol 2008; 20: 398-403. Go to original source... Go to PubMed...
    13. Furst DE, Breedveld FC, Kalden JR, et al. Updated consensus statement on biological agents for the treatment of rheumatic disease. 2007. Ann Rheum Dis 2007; 66: iii2-iii22. Go to original source... Go to PubMed...
    14. Coates LC, Cawkwell LS, Ng NWF, et al. Real life experience confirms sustained response to long-term biologics and switching in ankylosing spondylitis. Rheumatology 2008; 47: 897-900. Go to original source... Go to PubMed...
    15. Barlow JH, Wright CC, Williams B, Keat A. Work disability among people with ankylosing spondylitis. Arthritis Rheum 2001; 45: 424-429. Go to original source...
    16. Keat AC, Gaffney K, Gilbert AK, Hartus C, Leader J. Influence of biologic therapy on retur to work in people with work diasability due to ankylosing spondylitis. Rheumatology 2008; 47: 481-483. Go to original source... Go to PubMed...

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.